Actualité
-
2011-11-09 Consolidated Financial Interim Report for the Third Quarter 2011
-
2011-11-07 Evolva receives clearance to move EV-077 into Phase IIa
-
2011-10-26 CMC Biologics Announces Agreement with Daiichi Sankyo Company to Develop and Manufacture Antibodies
-
2011-10-27 i2S Progression des résultats semestriels 2011
-
2011-10-27 Les biomarqueurs épigénétiques de MDxHealth sont capables de confirmer la présence du cancer du poumon à partir d’échantillons d’expectorations
-
2011-10-24 Nomination de Philippe Valachs au poste de Secrétaire Général
-
2011-09-15 Study shows use of PediGuard reduced the incidence of clinically relevant misplaced
-
2011-10-26 OctoPlus successfully completes equity offering with gross proceeds of € 4 million
-
2011-10-25 OctoPlus launches equity offering with aimed proceeds of € 4 million
-
2011-09-26 SpineGuard secures $6.2 million to further extend its PediGuard franchise